Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort.
Ruscitti P, Pantano I, Perrotta FM, Celletti E, Volpe P, Ciliento MS, Marino V, Raimondi M, Gaggiano E, Mauro D, Cataldi G, Italiano N, Di Muzio C, Navarini L, Zicolella R, Gabini M, Cipollone F, Lubrano E, Giacomelli R, Ciccia F, Cipriani P. Ruscitti P, et al. Among authors: lubrano e. Clin Exp Rheumatol. 2024 Jan;42(1):69-76. doi: 10.55563/clinexprheumatol/tpp63h. Epub 2023 Jul 24. Clin Exp Rheumatol. 2024. PMID: 37497733 Free article.
Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs.
Atteno M, Peluso R, Costa L, Padula S, Iervolino S, Caso F, Sanduzzi A, Lubrano E, Del Puente A, Scarpa R. Atteno M, et al. Among authors: lubrano e. Clin Rheumatol. 2010 Apr;29(4):399-403. doi: 10.1007/s10067-009-1340-7. Clin Rheumatol. 2010. PMID: 20066450 Clinical Trial.
249 results